Eton

1 products tracked · names used in filings: Eton, Eton Pharmaceuticals, Inc.

Upcoming milestones

Mon 29 Mar 2027🇺🇸 PDUFA datecompany-announcedin 135 days

LIBERVANT: PDUFA target action date (seizure clusters in patients with epilepsy, adding ages 6 to 11 to the label)

Eton Pharmaceuticals, Inc. (ETON); diazepam; NDA; status: set; "The NDA has a Prescription Drug User Fee Act (PDUFA) target action date of March 29, 2027."; filed 2026-10-14 · source

Recent milestones

Wed 25 Feb 2026🇺🇸 PDUFA datecompany-announced

ET-600: PDUFA target action date

Eton Pharmaceuticals, Inc. (ETON); NDA; status: set; "….5 million, representing 129% growth over Q3 2024 and the 19th straight quarter of sequential product sales growth ● Q3 2025 basic and fully diluted GAAP EPS of $(0.07), non-GAAP fully diluted EPS of $0.04, and Adjusted EBITDA of $2.9 million ● ET-600 NDA accepted for review, assigned PDUFA date of February 25,…"; filed 2025-11-06 · source

Wed 25 Feb 2026🇺🇸 FDA approval

FDA approves Desmoda (desmopressin acetate): new dosage form

Eton; NDA219873; New dosage form; solution · source

Products

	Product	Status	Approved
🇺🇸	Desmoda desmopressin acetate	Approved	2026-02-25

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.